Literature DB >> 7929589

Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase).

J P Tassan1, S J Schultz, J Bartek, E A Nigg.   

Abstract

The activity of cyclin-dependent kinases (cdks) depends on the phosphorylation of a residue corresponding to threonine 161 in human p34cdc2. One enzyme responsible for phosphorylating this critical residue has recently been purified from Xenopus and starfish. It was termed CAK (for cdk-activating kinase), and it was shown to contain p40MO15 as its catalytic subunit. In view of the cardinal role of cdks in cell cycle control, it is important to learn if and how CAK activity is regulated during the somatic cell cycle. Here, we report a molecular characterization of a human p40MO15 homologue and its associated CAK activity. We have cloned and sequenced a cDNA coding for human p40MO15, and raised specific polyclonal and monoclonal antibodies against the corresponding protein expressed in Escherichia coli. These tools were then used to demonstrate that p40MO15 protein expression and CAK activity are constant throughout the somatic cell cycle. Gel filtration suggests that active CAK is a multiprotein complex, and immunoprecipitation experiments identify two polypeptides of 34 and 32 kD as likely complex partners of p40MO15. The association of the three proteins is near stoichiometric and invariant throughout the cell cycle. Immunocytochemistry and biochemical enucleation experiments both demonstrate that p40MO15 is nuclear at all stages of the cell cycle (except for mitosis, when the protein redistributes throughout the cell), although the p34cdc2/cyclin B complex, one of the major purported substrates of CAK, occurs in the cytoplasm until shortly before mitosis. The absence of obvious changes in CAK activity in exponentially growing cells constitutes a surprise. It suggests that the phosphorylation state of threonine 161 in p34cdc2 (and the corresponding residue in other cdks) may be regulated primarily by the availability of the cdk/cyclin substrates, and by phosphatase(s).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929589      PMCID: PMC2120215          DOI: 10.1083/jcb.127.2.467

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  82 in total

Review 1.  Creative blocks: cell-cycle checkpoints and feedback controls.

Authors:  A W Murray
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

2.  Coupling of mitosis to the completion of S phase in Xenopus occurs via modulation of the tyrosine kinase that phosphorylates p34cdc2.

Authors:  C Smythe; J W Newport
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

4.  Distinct forms of human CDC2 identified by novel monoclonal antibodies.

Authors:  J Lukás; G Draetta; J Bartek
Journal:  Eur J Biochem       Date:  1992-07-01

5.  Novel protein kinases expressed in human breast cancer.

Authors:  W G Cance; R J Craven; T M Weiner; E T Liu
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

6.  Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein.

Authors:  M G Lee; C J Norbury; N K Spurr; P Nurse
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

7.  Cyclin A is required for the onset of DNA replication in mammalian fibroblasts.

Authors:  F Girard; U Strausfeld; A Fernandez; N J Lamb
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

8.  The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues.

Authors:  D Fesquet; J C Labbé; J Derancourt; J P Capony; S Galas; F Girard; T Lorca; J Shuttleworth; M Dorée; J C Cavadore
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

9.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  Protein localization to the nucleolus: a search for targeting domains in nucleolin.

Authors:  M S Schmidt-Zachmann; E A Nigg
Journal:  J Cell Sci       Date:  1993-07       Impact factor: 5.285

View more
  81 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34cdc2 in HeLa cervical carcinoma cells.

Authors:  T Theron; L Böhm
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

3.  Tumor extension and cell proliferation in adenocarcinomas of the lung.

Authors:  M Shoji; Y Dobashi; S Morinaga; S X Jiang; T Kameya
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

4.  CAK-independent activation of CDK6 by a viral cyclin.

Authors:  P Kaldis; P M Ojala; L Tong; T P Mäkelä; M J Solomon
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

5.  The rice cyclin-dependent kinase-activating kinase R2 regulates S-phase progression.

Authors:  Tanja Fabian-Marwedel; Masaaki Umeda; Margret Sauter
Journal:  Plant Cell       Date:  2002-01       Impact factor: 11.277

6.  Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.

Authors:  M Rossignol; I Kolb-Cheynel; J M Egly
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

7.  Spatial positive feedback at the onset of mitosis.

Authors:  Silvia D M Santos; Roy Wollman; Tobias Meyer; James E Ferrell
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

8.  T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity.

Authors:  S Larochelle; J Chen; R Knights; J Pandur; P Morcillo; H Erdjument-Bromage; P Tempst; B Suter; R P Fisher
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

9.  CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma.

Authors:  Qian Ran; Feng Jin; Yang Xiang; Lixin Xiang; Qiushi Wang; Fengjie Li; Li Chen; Yuan Zhang; Chun Wu; Luping Zhou; Yanni Xiao; Lili Chen; Jiang Wu; Jiang F Zhong; Shengwen Calvin Li; Zhongjun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

10.  Origin licensing and p53 status regulate Cdk2 activity during G(1).

Authors:  Kathleen R Nevis; Marila Cordeiro-Stone; Jeanette Gowen Cook
Journal:  Cell Cycle       Date:  2009-06-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.